Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder caused by mutations in the polycystic kidney disease (PKD) gene. Although tolvaptan has benefits for renal involvement, the different effects depending on the gene mutation type are unknown. Thus, we explore th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Exp Nephrol
Egile Nagusiak: Moriyama, Tomofumi, Nakayama, Yosuke, Soejima, Mikiko, Yokota, Yunosuke, Ota, Kanji, Ito, Sakuya, Kodama, Goh, Nakamura, Nao, Kurokawa, Yuka, Yano, Junko, Ueda, Utako, Takamiya, Yoshimi, Kaida, Yusuke, Hazama, Takuma, Shibata, Ryo, Koda, Yoshiro, Fukami, Kei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Singapore 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7925507/
https://ncbi.nlm.nih.gov/pubmed/33141305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-020-01988-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak